Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For April 18 (CHSI, SXCI, ABT, PFE, HAL, TXT, YHOO, IBM, INTC)

RELATED NEWS
Trade INTC now with 

Gainers:

Catalyst Health Solutions, Inc. (CHSI: Quote) is gaining 35 percent to $86.00. The company and SXC Health Solutions (SXCI: Quote, SXC.TO) would combine in a cash and stock transaction valued at about $4.4 billion. Catalyst shareholders will receive $28.00 cash and 0.6606 SXC shares for each Catalyst share, implying a purchase price of $81.02 per Catalyst share. SXCI is rising 16 percent to $92.92.

Abbott Laboratories (ABT: Quote) is rising 1 percent to $61.22. The company's first quarter earnings and sales grew from the previous year period and were above Wall Street view. In addition, the company raised its full-year 2012 ongoing earnings per share guidance.

Halliburton Co. (HAL: Quote) is up over 2 percent to $33.40. The company's profit increased from the previous year. consolidated revenue improved 30 percent from the year-ago quarter and were above consensus.

Textron Inc. (TXT: Quote) is up 1 percent to $28.01. The company's first quarter profit increased from the year-ago quarter and revenues rose 15.2 percent. Both earnings per share revenues were above analysts' estimates. Meanwhile, the company confirmed its guidance of 2012.

Yahoo! Inc. (YHOO: Quote) is up 3 percent to $15.47 as the company's first quarter profit and revenues increased from the previous year and also topped Wall Street view. The company guided second quarter revenues, excluding traffic acquisition costs, in-line with analysts' estimate.

Decliners:

Pfizer Inc. (PFE: Quote) is down 0.45 percent to $22.21. The company is reportedly close to selling its infant-nutrition business to Nestlé SA (NSRGY.PK) for at least $9 billion.

Cree, Inc. (CREE: Quote) is down over 5 percent to $30.16 as the company's third quarter profit plunged from the year-ago quarter. Non-GAAP earnings per share were below Wall Street view by a penny. Revenue rose 30 percent, but were below consensus. In addition, the company expects its fourth quarter results below analysts' expectations.

International Business Machines Corp. (IBM: Quote) is falling 2 percent to $203. The company's first quarter profit increased from the previous year and operating earnings per share were above Wall Street view. However, revenues fell short of analysts' estimate. Meanwhile, the company raised its full-year 2012 operating earnings guidance.

Intel Corp. (INTC: Quote) is down over 2 percent to $27.70. The company's first quarter profit declined from the year-ago quarter, but were above consensus. Net revenue increased from the prior year and also were above consensus.

Register
To receive FREE breaking news email alerts for Intel Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The U.K. economy grew more than estimated in the second quarter and the current account deficit widened from the first quarter, the Office for National Statistics said Tuesday. Gross domestic product grew 0.9 percent sequentially, up from the prior estimate of 0.8 percent. The annual growth was confirmed at 3.2 percent. Eurozone inflation slowed in September, as expected, to the lowest since late 2009 and the unemployment rate remained stable at a double digit level in August putting pressure on the European Central Bank to launch a full-blown easing. Inflation came in at 0.3 percent, slower than August's 0.4 percent. This was the lowest since October 2009, when prices fell 0.1 percent. Chinese authorities on Tuesday eased some rules for mortgages for buying a second home, in a bid to boost the housing market. The People's Bank of China and the China Banking Regulatory Commission said in a joint statement that buyers who already own one apartment, but have paid off the mortgage...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.